-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>.
Recently, Dong Wenfei's team from the Institute of Medical Engineering, Chinese Academy of Sciences has developed a particle size - charge double-conversion nanoassembly triggered by near-infrared light for the combined light-controlled chemotherapy and immunotherapy of breast cancer
In this study, the researchers assembled a new nano-drug carrier
This light-driven charge - particle size double-conversion nanoassembly can carry drugs deep into the tumor and diffuse throughout the tissue, exerting the effect of light-controlled chemotherapy, and enhancing tumor immunogenicity
The above work provides a novel platform for the safe and efficient comprehensive treatment of breast cancer
The research was supported by the National Key R&D Program, the National Natural Science Foundation of China, and the Natural Science Foundation of Jiangsu Province
Paper link: https://pubmed.
Figure 1.
Figure 2.